drugset / Trial / NCT07378228

Weak Pulse at Yang and Wiry Pulse at Yin Theory

NCT07378228

Completed 70 enrolled Xikun Li
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a clinical study to evaluate the effectiveness and explore the possible working mechanisms of a traditional Chinese herbal formula called Yixin Powder. The study focuses on patients with stable angina pectoris (chest pain) caused by coronary heart disease (CHD), who are diagnosed with a specific Chinese medicine pattern known as "qi deficiency and blood stasis," based on the "weak pulse at yang and wiry pulse at yin" theory. The study hypothesizes that adding Yixin Powder to standard Western medication will be beneficial for these patients. To test this, participants diagnosed with this condition will be randomly assigned to one of two groups. One group will receive standard medication alone, while the other group will receive the same standard medication plus Yixin Powder. The effects of the treatments will be compared between the two groups.

Timeline

Start
2023-07-01
Primary completion
2024-06-01
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Yixin Powder Traditional medicine (herbal / TCM) 30 g Oral
Background Aspirin Small molecule 100 mg Oral
Background Atorvastatin Small molecule 20 mg Oral
Background Metoprolol Other / unclassified 23.75 mg Oral